Nivolumab Shows Significant Overall Survival Benefit in Metastatic Gastric Cancer

Ian Chau, MD, FRCP of Royal Marsden Hospital discusses how Nivolumab Shows Significant Overall Survival Benefit in Metastatic Gastric Cancer at ASCO GI 2017